Seongnam, South Korea

Jeong Eun Choi

This inventor holds 1 USPTO granted patent. Top assignees: Lifecord Inc., Corp., Other. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeong Eun Choi. Retrieved from https://idiyas.com/inventor/jeong-eun-choi-dpvzp2hv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:

goldMedal1 out of 4 
 
Lifecord Inc., Corp.
 patents
silverMedal1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeong Eun Choi: Innovator in Cell Therapy

Introduction

Jeong Eun Choi is a notable inventor based in Seongnam, South Korea. He has made significant contributions to the field of cell therapy through his innovative research and patents. His work focuses on the isolation and cultivation of multipotent progenitor cells, which hold great potential for medical applications.

Latest Patents

Jeong Eun Choi holds a patent for a "Method for isolating and culturing multipotent progenitor cells from umbilical cord blood." This method allows for the effective differentiation of cells into various types, including neurons, osteoblasts, myoblasts, endothelial cells, hepatocytes, and dendritic cells. The implications of this patent are profound, as these cells can be utilized in cell therapy, restoration techniques, and organ production. He has 1 patent to his name.

Career Highlights

Throughout his career, Jeong Eun Choi has worked with Lifecord Inc., a company dedicated to advancing stem cell technology. His expertise in the field has positioned him as a key figure in the development of innovative medical solutions.

Collaborations

Jeong Eun Choi has collaborated with notable colleagues, including Myoung Woo Lee and Mal Sook Yang, who have contributed to his research endeavors.

Conclusion

Jeong Eun Choi's work in isolating and culturing multipotent progenitor cells represents a significant advancement in the field of regenerative medicine. His contributions have the potential to transform therapeutic approaches and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…